Cargiulo T (2007). «Understanding the health impact of alcohol dependence». Am J Health Syst Pharm. 64 (5 Suppl 3): S5–11. PMID17322182. doi:10.2146/ajhp060647.
Wetterling T; Junghanns, K (2000). «Psychopathology of alcoholics during withdrawal and early abstinence». Eur Psychiatry. 15 (8): 483–8. PMID11175926. doi:10.1016/S0924-9338(00)00519-8.
Bandelow, B.; Wedekind, D.; Leon, T. (2007). «Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention.». Expert Rev Neurother. 7 (7): 769–81. doi:10.1586/14737175.7.7.769.
Owen, RT. (2007). «Pregabalin: its efficacy, safety and tolerability profile in generalized anxiety.». Drugs Today (Barc). 43 (9): 601–10. doi:10.1358/dot.2007.43.9.1133188.
Cargiulo T (2007). «Understanding the health impact of alcohol dependence». Am J Health Syst Pharm. 64 (5 Suppl 3): S5–11. PMID17322182. doi:10.2146/ajhp060647.
Wetterling T; Junghanns, K (2000). «Psychopathology of alcoholics during withdrawal and early abstinence». Eur Psychiatry. 15 (8): 483–8. PMID11175926. doi:10.1016/S0924-9338(00)00519-8.
Etkin A, Prater KE, Schatzberg AF, Menon V, Greicius MD. (2009). Disrupted amygdalar subregion functional connectivity and evidence of a compensatory network in generalized anxiety disorder. Arch Gen Psychiatry. 66(12):1361-72. PMID 19996041